HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,592 | +77.6% | 6,400 | +100.0% | 0.00% | – |
| Q2 2023 | $3,712 | +75.6% | 3,200 | +128.6% | 0.00% | – |
| Q1 2023 | $2,114 | -39.6% | 1,400 | 0.0% | 0.00% | – |
| Q4 2022 | $3,500 | -41.7% | 1,400 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $6,000 | +50.0% | 1,400 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -50.0% | 1,400 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $8,000 | -38.5% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $13,000 | -13.3% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | -31.8% | 1,400 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $22,000 | -4.3% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $23,000 | -23.3% | 1,400 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $30,000 | +42.9% | 1,400 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $21,000 | 0.0% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $21,000 | +31.2% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $16,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|